GSK plc
Holdings History for CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC)
- Symbol
- CVAC
- Investment type
- Equity / Common Shares, par value (euro)0.12 per share
- Latest Disclosed Shares Owned
- 0 shares
- Security Ownership %
- 0%
GSK plc ownership in CureVac N.V. Common Shares, par value (euro)0.12 per share (CVAC)
05 Dec 2025 - GSK plc has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of CureVac N.V. Common Shares, par value (euro)0.12 per share (CVAC).
This represents 0% ownership of the company.
In their previous filing dated 13 Aug 2025, GSK plc had reported owning 16,591,937 shares, indicating a decrease of +100%.
.
| Reporting Name | Ownership % | Change | Value $ | Shares owned | Change | Activity % | Price | Form | Report date | Filing time |
|---|---|---|---|---|---|---|---|---|---|---|
| GSK plc | 0% | -100% | $0 | 0 | -16,591,937 | -100% | $5.30 | 13D/A | 03 Dec 2025 | 05 Dec 2025, 16:23 |
| GSK plc | 74% | $90,591,976 | 16,591,937 | $5.46 | 13D | 07 Aug 2025 | 13 Aug 2025, 18:05 |